SAAB AB B O.N./ SE0021921269 /
2024-06-07 7:53:18 PM | Chg. +1.1300 | Volume | Bid9:59:59 PM | Ask9:59:52 PM | High | Low |
---|---|---|---|---|---|---|
23.9600EUR | +4.95% | 8,505 Turnover: 199,310 |
-Bid Size: - | -Ask Size: - | 23.9600 | 22.4200 |
GlobeNewswire
06-03
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational G...
Newsfile Corp
04-11
Tor Holding and ELIE SAAB Announce Partnership for Dual Real Estate Debut in Turkey
GlobeNewswire
04-04
Schneider Electric announces global winners of second edition of its Sustainability Impact Awards
GlobeNewswire
04-03
SK hynix announces semiconductor advanced packaging investment in Purdue Research Park
GlobeNewswire
2023-12-19
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire
2023-11-29
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire
2023-11-13
Bombardier Defense Delivers Seventh Global Aircraft for Saab’s GlobalEye Airborne Surveillance Solut...
GlobeNewswire
2023-11-03
Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial o...
GlobeNewswire
2023-10-05
uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of M...